Unknown

Dataset Information

0

A single-dose ChAdOx1-vectored vaccine provides complete protection against Nipah Bangladesh and Malaysia in Syrian golden hamsters.


ABSTRACT: Nipah virus (NiV) is a highly pathogenic re-emerging virus that causes outbreaks in South East Asia. Currently, no approved and licensed vaccine or antivirals exist. Here, we investigated the efficacy of ChAdOx1 NiVB, a simian adenovirus-based vaccine encoding NiV glycoprotein (G) Bangladesh, in Syrian hamsters. Prime-only as well as prime-boost vaccination resulted in uniform protection against a lethal challenge with NiV Bangladesh: all animals survived challenge and we were unable to find infectious virus either in oral swabs, lung or brain tissue. Furthermore, no pathological lung damage was observed. A single-dose of ChAdOx1 NiVB also prevented disease and lethality from heterologous challenge with NiV Malaysia. While we were unable to detect infectious virus in swabs or tissue of animals challenged with the heterologous strain, a very limited amount of viral RNA could be found in lung tissue by in situ hybridization. A single dose of ChAdOx1 NiVB also provided partial protection against Hendra virus and passive transfer of antibodies elicited by ChAdOx1 NiVB vaccination partially protected Syrian hamsters against NiV Bangladesh. From these data, we conclude that ChAdOx1 NiVB is a suitable candidate for further NiV vaccine pre-clinical development.

SUBMITTER: van Doremalen N 

PROVIDER: S-EPMC6581282 | biostudies-literature | 2019 Jun

REPOSITORIES: biostudies-literature

altmetric image

Publications

A single-dose ChAdOx1-vectored vaccine provides complete protection against Nipah Bangladesh and Malaysia in Syrian golden hamsters.

van Doremalen Neeltje N   Lambe Teresa T   Sebastian Sarah S   Bushmaker Trenton T   Fischer Robert R   Feldmann Friederike F   Haddock Elaine E   Letko Michael M   Avanzato Victoria A VA   Rissanen Ilona I   LaCasse Rachel R   Scott Dana D   Bowden Thomas A TA   Gilbert Sarah S   Munster Vincent V  

PLoS neglected tropical diseases 20190606 6


Nipah virus (NiV) is a highly pathogenic re-emerging virus that causes outbreaks in South East Asia. Currently, no approved and licensed vaccine or antivirals exist. Here, we investigated the efficacy of ChAdOx1 NiVB, a simian adenovirus-based vaccine encoding NiV glycoprotein (G) Bangladesh, in Syrian hamsters. Prime-only as well as prime-boost vaccination resulted in uniform protection against a lethal challenge with NiV Bangladesh: all animals survived challenge and we were unable to find inf  ...[more]

Similar Datasets

| S-EPMC6309986 | biostudies-literature
| S-EPMC7199786 | biostudies-literature
| S-EPMC3648995 | biostudies-literature
| S-EPMC3953481 | biostudies-literature
| S-EPMC3547834 | biostudies-literature
| S-EPMC5094696 | biostudies-literature
| S-EPMC3557903 | biostudies-literature
| S-EPMC5930900 | biostudies-literature
| S-EPMC4192357 | biostudies-literature
| S-EPMC8577872 | biostudies-literature